HQY earnings analysis
What we found in HQY's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
HealthEquity delivered solid year-over-year growth in the second quarter, with revenue up 8% to $350.7 million, gross margin reaching 73.6%, operating margin reaching 28.1% and diluted EPS increasing to $0.78. Growth was led by custodial revenue and expanding HSA assets, while technology-related efficiencies reduced service costs. Operating cash flow improved, but cash declined to $256.0 million after $231.1 million of stock repurchases and $26.9 million of debt prepayments. The principal offsets are interest-rate sensitivity, hedge losses and unresolved cybersecurity litigation; the company provided no new quantitative guidance and stated that risk factors were materially unchanged.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue Growth and Margin Expansion
- Second-quarter revenue increased 8% year over year to $350.7 million from $325.8 million. Gross profit rose to $258.0 million, producing a 73.6% gross margin versus 71.4% in the prior-year quarter, while operating income increased to $98.7 million and operating margin expanded to 28.1% from 27.5%.
- EPS and Net Income Improved
- Diluted EPS increased to $0.78 from $0.68 year over year, while net income rose 10% to $65.6 million from $59.9 million. Interest expense declined 16% to $12.6 million, partially offsetting higher operating expenses and a higher tax provision.
- Broad-Based Revenue Growth
- All revenue streams grew year over year: custodial revenue increased 10% to $175.9 million, service revenue rose 6% to $124.4 million, and interchange revenue increased 5% to $50.4 million. Management attributed growth to higher HSA assets, Total Accounts, marketplace revenue and payment-card spending.
- HSA Scale Continues to Expand
- HSA Assets increased 14% to $37.9 billion, including a 28% increase in HSA investments to $20.6 billion. HSAs administered rose 8% to 10.7 million and Total Accounts increased 4% to 17.8 million, although CDBs declined 2% to 7.0 million.
- Operating Cash Flow Strengthened
- Operating cash flow increased to $233.7 million for the six months ended July 31, 2026 from $200.6 million in the prior-year period. Capital expenditures were $32.1 million, or approximately 4.5% of six-month revenue, as the company continued investing in software and systems modernization.
- Debt Reduction and Liquidity
- The company prepaid $26.9 million of debt during the six months and repurchased $231.1 million of common stock. Management stated that existing cash, cash equivalents and revolving-credit availability should fund operating and capital-expenditure needs for at least the next 12 months.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Variable-Rate Debt Exposure
- The filing states that there were no material changes to the risk factors from the January 31, 2026 Form 10-K. Nevertheless, the company remains exposed to interest-rate changes: its $335.0 million revolving balance carried a 5.08% rate at July 31, 2026, and a 1 percentage-point increase would add approximately $3.4 million of annual interest expense.
- Custodial Yield Sensitivity
- HSA custodial revenue remains sensitive to interest rates and contract repricing. The company had $16.7 billion of HSA cash expected to reprice under fixed-rate contracts, with an average annualized yield of 3.9%, while the filing states that a sustained decline in rates could reduce custodial revenue.
- Hedge Mark-to-Market Losses
- Derivative hedge liabilities increased materially as Treasury bond forwards were carried at $85.2 million of liabilities at July 31, 2026 versus $14.9 million at January 31, 2026. The company also expects $6.1 million of existing net hedge losses to be reclassified into custodial revenue within the next 12 months.
- Cybersecurity Litigation
- The company continues to face litigation and regulatory inquiries related to a fiscal 2025 cybersecurity incident. No loss accrual was recorded because the potential loss could not be reasonably estimated, but the filing states that an unfavorable outcome could materially affect financial position, results of operations and cash flows.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.78
- Gross margin
- 73.6%
- Operating margin
- 28.1%
- Segment
- Single operating segment; no segment-level revenue breakdown disclosed.
- Segment
- Service revenue: $124.4 million, up 6% year over year.
- Segment
- Custodial revenue: $175.9 million, up 10% year over year.
- Segment
- Interchange revenue: $50.4 million, up 5% year over year.
What they said about what is next.
The 10-Q does not provide new quantitative revenue or EPS guidance. Management provides qualitative outlook commentary, including expectations for higher service, custodial and interchange revenue, continued capital expenditures, and sufficient liquidity for at least the next 12 months.
The filing reads better than the one before it.
What came before.
- 10-Q · May 28, 2026
- HealthEquity, Inc. reported strong Q1 2026 results with revenue of $354.6 million, surpassing estimates of $352.6 million. The net income increased by 29% to $69.4 million, reflecting significant year-over-year growth,…
- 10-K · March 17, 2026
- HealthEquity positions itself as the market leader in HSAs and complementary consumer-directed benefits with scale (10.6 million HSAs and $36.5 billion in HSA Assets) and an integrated, technology-led B2B2C…
- 10-Q · December 3, 2025
- HealthEquity reported Q3 revenue of $322,164,000, up $21,732,000 (7.2%) year-over-year, with gross margin expanding to 70.8% and operating income rising to $78,695,000 (operating margin 24.4%). Diluted EPS improved to…
- 10-Q · September 2, 2025
- HealthEquity reported solid quarter with revenue of $325,835,000, up from $299,928,000 a year ago, driven by strong custodial and interchange growth. Gross margin expanded to 71.4% and operating margin widened to 27.5%,…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing HQY makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever